| Search for content and authors |
|
|
| |
 |
dr Wioleta Maruszak
|
| e-mail: | ***@ifarm.eu |
| phone: | +48-22-4563893 |
| fax: | +48-22-4563838 |
| web: | |
| interest(s): | |
|
Affiliation: |
Instytut Farmaceutyczny |
Participant: |
|
Participant: |
| began: | 2008-05-25 |
| ended: | 2008-05-29 |
| Presented: | |
|
|
|
Participant: |
| began: | 2012-05-29 |
| ended: | 2012-06-02 |
| Presented: | |
|
|
|
Participant: |
|
Publications: |
- An application of accelerator mass spectrometry (AMS) in pediatric clinical studies. Paracetamol, midazolam and spironolactone radiosynthesis and certification.
- CHARACTERIZATION OF ARIPIPRAZOLE SOLVATE WITH ETHANOL AND POLYMORPHIC FORMS PRODUCED DURING ITS HEATING
- Development of HPLC and GC methods for analysis of Zolmitriptan of pharmaceutical purity
- Evaluation of potential genotoxic impurities in prasugrel intermediate by HPLC chromatography
- Improved manufacturing process of bosentan monohydrate.
- New rosiglitazone salts
- ROPINIROL - GENERIC DRUG FOR PARKINSON'S DISEASE
- Simultaneous CE determination of counterion and possible impurity from synthetic route in pharmaceutical substance prasugrel hydrochloride.
- THE COMPARISON OF TWO VALIDATED HPLC METHODS FOR THE DETERMINATION OF (+)-CLOPIDOGREL HYDROGENSULFATE PURITY WITH THE USP METHOD.
|
